Mezoteliomi
Abstract
Maligni mezoteliom uvrščamo med redke rake, njegova incidenca pa še vedno narašča pri nas in v svetu. V Sloveniji smo zakonsko prepovedali proizvodnjo in uporabo azbesta leta 1996, vendar še nismo zmanjšali bremena te bolezni, ker je latentni čas med izpostavljenostjo azbestu ter obolevnostjo zelo dolg. Različne klinične raziskave so potrdile učinkovitost sistemskega zdravljenja, kot sta kombinaciji cisplatina in gemcitabina ter cisplatina in pemetrekseda. Do sedaj smo samo na Nizozemskem in v Sloveniji dokazali, da je sodobno kemoterapevtsko zdravljenje statistično značilno podaljšalo srednje celokupno preživetje celotne populacije bolnikov s to boleznijo.
Keywords
pljučni rak;mezoteliomi;maligni mezoteliomi;
Data
| Language: | Slovenian |
|---|---|
| Year of publishing: | 2012 |
| Typology: | 1.02 - Review Article |
| Organization: | OI - Institute of Oncology |
| UDC: | 616.24-006.6 |
| COBISS: |
1422459
|
| ISSN: | 1408-1741 |
| Parent publication: | Onkologija |
| Views: | 2297 |
| Downloads: | 721 |
| Average score: | 0 (0 votes) |
| Metadata: |
|
Other data
| Secondary language: | English |
|---|---|
| Secondary title: | Mesotheliomas |
| Secondary abstract: | Malignant mesothelioma is a rare type of cancer, the incidence of which is still increasing both in our country and also throughout the world. In Slovenia, the production and use of asbestos was prohibited in 1996, but we have not yet managed to reduce the burden of this disease due to the extremely long latency period between exposure to asbestos and incidence of the disease. Different clinical trials confirmed the effectiveness of systemic treatment, such as the combination of cisplatin and gemcitabin and the combination of cisplatin and pemetrexed. So far, only the Netherlands and Slovenia have managed to prove that modern chemotherapy treatment statistically significantly prolonged the median overall survival of the entire population of patients with this disease. |
| Secondary keywords: | Pleural neoplasms;Mesothelioma; |
| URN: | URN:NBN:SI |
| Pages: | str. 64-68, 112 |
| Volume: | ǂLetn. ǂ16 |
| Issue: | ǂšt. ǂ2 |
| Chronology: | dec. 2012 |
| ID: | 10956749 |
Recommended works:
Mezoteliomi
2012,
no subtitle data available
Novosti v zdravljenju pljučnega raka ASCO, Chicago, 1.-5. junij 2012
2012,
no subtitle data available
Mezoteliomi
2012,
no subtitle data available
The central role of survivin in proliferation and apoptosis of malignant pleural mesothelioma
2012,
no subtitle data available
P14/ARF-positive malignant pleural mesothelioma
2022,
ǂa ǂphenotype with distinct immune microenvironment